New York, NY (PRWEB) June 20, 2017
AMC Health, the leading provider of proven real-time virtual care solutions announced today their continued expansion and success in the clinical trials market. Similar to its approach in demonstrating positive outcomes in the healthcare market, AMC Health has been building a track record in the clinical trials marketplace by proving the value of eVisits to support virtual studies.
In a study concluded this year, the company’s telehealth solution supported a study in Alzheimer’s disease. The details of the successful results of which will be presented at the Annual DIA (Drug Information Association) conference in Chicago, on Wednesday June 21, 2017.
AMC Health has deployed its telehealth platform solution to support clinical trials in the areas of endocrinology, oncology, CNS, digestive diseases, and degenerative diseases, each of which have demonstrated evidence of feasibility, high satisfaction by patients and clinicians, and high correlation to data collected in the traditional in-person setting.
“We continue to see evidence across a growing number of therapeutic areas that telehealth eVisits present a viable alternative to traditional in-person visits, providing convenience to study participants, efficiencies to study budgets, and potential improvements in the quality of data collected,” said Michael O’Brien, President of AMC Health’s Clinical Trial Division.
AMC Health’s Part 11 compliant eVisit platform was designed to replace costly in-person study visits. Virtual visits enable observation, interaction, and secure data collection while subjects are away from research sites. The platform integrates (i) bi-directional video, (ii) biometric sensors, (iii) subjective data collection, and (iv) direct text capabilities which provide an immersive clinical trial experience with greater convenience for the patient, the clinical research site and other study team members.
About AMC Health
AMC Health’s Clinical Trials division provides a suite of solutions on a telehealth platform for Study Sponsors, CROs and Sites, to remotely collect biometric, observational and subjective data from study subjects at home, for use in clinical trials. AMC Health’s Clinical Trials platform is a 21 CFR Part 11 compliant solution to manage the complexities of clinical trial data collection. The platform utilizes a toolkit of Bluetooth-sensor devices, smartphone mobile applications and bi-directional video to create an e-visit to replace or augment traditional study visits. For more information, visit http://www.amchealth.com/solutions/clinical-trials.php